{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T04:50:25Z","timestamp":1793163025908,"version":"4.5.0"},"reference-count":96,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Life Sciences"],"published-print":{"date-parts":[[2022,10]]},"DOI":"10.1016\/j.lfs.2022.120908","type":"journal-article","created":{"date-parts":[[2022,8,24]],"date-time":"2022-08-24T00:15:32Z","timestamp":1661300132000},"page":"120908","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":36,"special_numbering":"C","title":["Effect of nanovesicular surface-functionalization via chitosan and\/or PEGylation on cytotoxicity of tamoxifen in induced-breast cancer model"],"prefix":"10.1016","volume":"307","author":[{"given":"Mohamed A.","family":"Megahed","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hossam S.","family":"El-Sawy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed M.","family":"Reda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fathy I.","family":"Abd-Allah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sherif K.","family":"Abu Elyazid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed E.","family":"Lila","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hatem R.","family":"Ismael","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khalid M.","family":"El-Say","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.lfs.2022.120908_bb0005","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.31557\/APJCP.2019.20.7.2015","article-title":"Global trend of breast cancer mortality rate: a 25-year study","volume":"20","author":"Azamjah","year":"2019","journal-title":"Asian Pac. J. Cancer Prev."},{"key":"10.1016\/j.lfs.2022.120908_bb0010","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1208\/s12249-018-0962-y","article-title":"Enhancing the therapeutic efficacy of tamoxifen citrate loaded span-based nano-vesicles on human breast adenocarcinoma cells","volume":"19","author":"Kassem","year":"2018","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.lfs.2022.120908_bb0015","first-page":"7","article-title":"Cancer statistics, 2022","volume":"72","author":"Siegel","year":"2022","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.lfs.2022.120908_bb0020","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.ijbiomac.2014.08.012","article-title":"Therapeutic efficacy and toxicity of tamoxifen loaded PLA nanoparticles for breast cancer","volume":"72","author":"Pandey","year":"2015","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.lfs.2022.120908_bb0025","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.msec.2015.11.019","article-title":"Tamoxifen-loaded poly(L-lactide) nanoparticles: development, characterization and in vitro evaluation of cytotoxicity","volume":"60","author":"Altmeyer","year":"2016","journal-title":"Mater. Sci. Eng. C"},{"key":"10.1016\/j.lfs.2022.120908_bb0030","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.ejphar.2016.04.017","article-title":"Delineating the molecular mechanisms of tamoxifen's oncolytic actions in estrogen receptor-negative cancers","volume":"781","author":"Radin","year":"2016","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.lfs.2022.120908_bb0035","doi-asserted-by":"crossref","DOI":"10.15252\/embr.201846557","article-title":"Tamoxifen mechanically reprograms the tumor microenvironment via HIF-1 A and reduces cancer cell survival","volume":"20","author":"Cortes","year":"2019","journal-title":"EMBO Rep."},{"key":"10.1016\/j.lfs.2022.120908_bb0040","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1517\/14728220902911509","article-title":"The potential role of estrogen receptors and the SRC family as targets for the treatment of breast cancer","volume":"13","author":"Spears","year":"2009","journal-title":"Expert Opin. Ther. Targets"},{"key":"10.1016\/j.lfs.2022.120908_bb0045","first-page":"S269","article-title":"Tamoxifen (ICI46,474) as a targeted therapy to treat and prevent breast cancer","author":"Jordan","year":"2006","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.lfs.2022.120908_bb0050","doi-asserted-by":"crossref","first-page":"3572","DOI":"10.1016\/j.ijcard.2013.05.068","article-title":"Systematic review of genuine versus spurious side-effects of beta-blockers in heart failure using placebo control: recommendations for patient information","volume":"168","author":"Barron","year":"2013","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.lfs.2022.120908_bb0055","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1016\/j.cherd.2013.11.024","article-title":"Efficient loading and entrapment of tamoxifen in human serum albumin based nanoparticulate delivery system by a modified desolvation technique","volume":"92","author":"Kouchakzadeh","year":"2014","journal-title":"Chem. Eng. Res. Des."},{"key":"10.1016\/j.lfs.2022.120908_bb0060","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1124\/dmd.111.039388","article-title":"Assessment of the impact of CYP3A polymorphisms on the formation of alpha hydroxytamoxifen and N -desmethyltamoxifen in human liver microsomes","volume":"40","author":"Mugundu","year":"2012","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.lfs.2022.120908_bb0065","doi-asserted-by":"crossref","first-page":"287","DOI":"10.2217\/pgs.14.171","article-title":"Pharmacogenomics toward personalized tamoxifen therapy for breast cancer","volume":"16","author":"Zembutsu","year":"2015","journal-title":"Pharmacogenomics"},{"key":"10.1016\/j.lfs.2022.120908_bb0070","doi-asserted-by":"crossref","first-page":"3551","DOI":"10.1039\/c4py00207e","article-title":"An assessment of nanosponges for intravenous and oral drug delivery of BCS class IV drugs: drug delivery kinetics and solubilization","volume":"5","author":"Stevens","year":"2014","journal-title":"Polym. Chem."},{"key":"10.1016\/j.lfs.2022.120908_bb0075","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1016\/j.jconrel.2015.08.052","article-title":"Dual drug delivery of tamoxifen and quercetin: regulated metabolism for anticancer treatment with nanosponges","volume":"220","author":"Lockhart","year":"2015","journal-title":"J. Control. Release"},{"key":"10.1016\/j.lfs.2022.120908_bb0080","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1016\/j.toxlet.2010.10.008","article-title":"Gene expression profiling of murine hepatic steatosis induced by tamoxifen","volume":"199","author":"Lee","year":"2010","journal-title":"Toxicol. Lett."},{"key":"10.1016\/j.lfs.2022.120908_bb0085","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.bbacli.2017.01.001","article-title":"Understanding breast cancer \u2013 the long and winding road","volume":"7","author":"Lukong","year":"2017","journal-title":"BBA Clin."},{"key":"10.1016\/j.lfs.2022.120908_bb0090","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.jconrel.2015.08.055","article-title":"Pharmacokinetic strategies to improve drug penetration and entrapment within solid tumors","volume":"219","author":"Al-Abd","year":"2015","journal-title":"J. Control. Release"},{"key":"10.1016\/j.lfs.2022.120908_bb0095","doi-asserted-by":"crossref","first-page":"3208","DOI":"10.2174\/1381612821666150531170621","article-title":"Intratumoral pharmacokinetics: challenges to nanobiomaterials","volume":"21","author":"Al-Abd","year":"2015","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.lfs.2022.120908_bb0100","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1081\/PDT-120003487","article-title":"Intratumoral administration of paclitaxel in an in situ gelling poloxamer 407 formulation","volume":"7","author":"Amiji","year":"2002","journal-title":"Pharm. Dev. Technol."},{"key":"10.1016\/j.lfs.2022.120908_bb0105","doi-asserted-by":"crossref","first-page":"193","DOI":"10.3389\/fonc.2013.00193","article-title":"Strategies to increase drug penetration in solid tumors","volume":"3","author":"Choi","year":"2013","journal-title":"Front. Oncol."},{"key":"10.1016\/j.lfs.2022.120908_bb0110","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1093\/sleep\/2.4.453","article-title":"Pubertal changes in daytime sleepiness","volume":"2","author":"Carskadon","year":"1980","journal-title":"Sleep"},{"key":"10.1016\/j.lfs.2022.120908_bb0115","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1038\/sj.onc.1204235","article-title":"Gene expression and amplification in breast carcinoma cells with intrinsic and acquired doxorubicin resistance","volume":"20","author":"Turton","year":"2001","journal-title":"Oncogene"},{"key":"10.1016\/j.lfs.2022.120908_bb0120","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0168-3659(01)00308-X","article-title":"Determinants of drug delivery and transport to solid tumors","volume":"74","author":"Au","year":"2001","journal-title":"J. Control. Release"},{"key":"10.1016\/j.lfs.2022.120908_bb0125","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1126\/science.1160809","article-title":"Understanding the Warburg effect: the metabolic requirements of cell proliferation","volume":"324","author":"Vander Heiden","year":"2009","journal-title":"Science"},{"key":"10.1016\/j.lfs.2022.120908_bb0130","doi-asserted-by":"crossref","first-page":"10636","DOI":"10.1021\/acsnano.8b06104","article-title":"Stimuli-responsive nano-architecture drug-delivery systems to solid tumor micromilieu: past, present, and future perspectives","volume":"12","author":"El-Sawy","year":"2018","journal-title":"ACS Nano"},{"key":"10.1016\/j.lfs.2022.120908_bb0135","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1038\/nrd3554","article-title":"Interfering with pH regulation in tumours as a therapeutic strategy","volume":"10","author":"Neri","year":"2011","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.lfs.2022.120908_bb0140","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.jconrel.2007.08.006","article-title":"Tumor pH-responsive flower-like micelles of poly(l-lactic acid)-b-poly(ethylene glycol)-b-poly(l-histidine)","volume":"123","author":"Lee","year":"2007","journal-title":"J. Control. Release"},{"key":"10.1016\/j.lfs.2022.120908_bb0145","doi-asserted-by":"crossref","first-page":"66","DOI":"10.3389\/fonc.2016.00066","article-title":"Pathophysiological basis for the formation of the tumor microenvironment","volume":"6","author":"Horsman","year":"2016","journal-title":"Front. Oncol."},{"key":"10.1016\/j.lfs.2022.120908_bb0150","first-page":"4921","article-title":"Response of aerobic and hypoxic cells in a solid tumor to adriamycin and cyclophosphamide and interaction of the drugs with radiation","volume":"42","author":"Tannock","year":"1982","journal-title":"Cancer Res."},{"key":"10.1016\/j.lfs.2022.120908_bb0155","first-page":"73","article-title":"Classification of antineoplastic agents by their selective toxicities toward oxygenated and hypoxic tumor cells","volume":"41","author":"Teicher","year":"1981","journal-title":"Cancer Res."},{"key":"10.1016\/j.lfs.2022.120908_bb0160","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/0142-9612(92)90028-M","article-title":"Biodegradable polymers. II. Degradation characteristics of hydrolysis-sensitive poly[(organo)phosphazenes]","volume":"13","author":"Crommen","year":"1992","journal-title":"Biomaterials"},{"key":"10.1016\/j.lfs.2022.120908_bb0165","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.7150\/thno.14858","article-title":"The smart drug delivery system and its clinical potential","volume":"6","author":"Liu","year":"2016","journal-title":"Theranostics"},{"key":"10.1016\/j.lfs.2022.120908_bb0170","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1038\/nmat3776","article-title":"Stimuli-responsive nanocarriers for drug delivery","volume":"12","author":"Mura","year":"2013","journal-title":"Nat. Mater."},{"key":"10.1016\/j.lfs.2022.120908_bb0175","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.760423","article-title":"Hyaluronidase and pH dual-responsive nanoparticles for targeted breast cancer stem cells","volume":"11","author":"Li","year":"2021","journal-title":"Front. Oncol."},{"key":"10.1016\/j.lfs.2022.120908_bb0180","doi-asserted-by":"crossref","first-page":"354","DOI":"10.3389\/fphys.2013.00354","article-title":"Acidic tumor microenvironment and pH-sensing G protein-coupled receptors","volume":"4","author":"Justus","year":"2013","journal-title":"Front. Physiol."},{"key":"10.1016\/j.lfs.2022.120908_bb0185","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1002\/ijc.27782","article-title":"Contribution of Na+, HCO3- cotransport to cellular pH control in human breast cancer: a role for the breast cancer susceptibility locus NBCn1 (SLC4A7)","volume":"132","author":"Boedtkjer","year":"2013","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.lfs.2022.120908_bb0190","doi-asserted-by":"crossref","first-page":"9910","DOI":"10.3390\/ijms22189910","article-title":"Effect of exogenous pH on cell growth of breast cancer cells","volume":"22","author":"Lee","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.lfs.2022.120908_bb0195","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/S1357-4310(99)01615-9","article-title":"Causes and consequences of tumour acidity and implications for treatment","volume":"6","author":"Stubbs","year":"2000","journal-title":"Mol. Med. Today"},{"key":"10.1016\/j.lfs.2022.120908_bb0200","doi-asserted-by":"crossref","first-page":"4976","DOI":"10.1016\/j.biomaterials.2011.03.050","article-title":"Hollow chitosan-silica nanospheres as pH-sensitive targeted delivery carriers in breast cancer therapy","volume":"32","author":"Deng","year":"2011","journal-title":"Biomaterials"},{"key":"10.1016\/j.lfs.2022.120908_bb0205","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.nano.2013.08.009","article-title":"Enhanced tumor delivery and antitumor activity in vivo of liposomal doxorubicin modified with MCF-7-specific phage fusion protein","volume":"10","author":"Wang","year":"2014","journal-title":"Nanomedicine Nanotechnol.Biol. Med."},{"key":"10.1016\/j.lfs.2022.120908_bb0210","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.xphs.2016.07.007","article-title":"Maximizing the therapeutic efficacy of imatinib mesylate\u2013loaded niosomes on human colon adenocarcinoma using box-behnken design","volume":"106","author":"Kassem","year":"2017","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.lfs.2022.120908_bb0215","doi-asserted-by":"crossref","first-page":"10938","DOI":"10.1021\/acs.chemrev.5b00046","article-title":"New developments in liposomal drug delivery","volume":"115","author":"Pattni","year":"2015","journal-title":"Chem. Rev."},{"key":"10.1016\/j.lfs.2022.120908_bb0220","doi-asserted-by":"crossref","first-page":"262","DOI":"10.3109\/02652048.2011.646330","article-title":"Trigger release liposome systems: local and remote controlled delivery?","volume":"29","author":"Bibi","year":"2012","journal-title":"J. Microencapsul."},{"key":"10.1016\/j.lfs.2022.120908_bb0225","doi-asserted-by":"crossref","first-page":"4026","DOI":"10.1039\/b923535n","article-title":"Liposomes as \u2018smart\u2019 pharmaceutical nanocarriers","volume":"6","author":"Sawant","year":"2010","journal-title":"Soft Matter"},{"issue":"Suppl 2","key":"10.1016\/j.lfs.2022.120908_bb0230","doi-asserted-by":"crossref","first-page":"S81","DOI":"10.1016\/S0928-0987(00)00166-4","article-title":"Drug targeting","volume":"11","author":"Torchilin","year":"2000","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.lfs.2022.120908_bb0235","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/j.ijpharm.2017.06.052","article-title":"Polymeric nanoparticles: promising platform for drug delivery","volume":"528","author":"El-Say","year":"2017","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.lfs.2022.120908_bb0240","doi-asserted-by":"crossref","DOI":"10.3109\/08982104.2015.1029495","article-title":"Diacerein niosomal gel for topical delivery: development, in vitro and in vivo assessment","volume":"26","author":"El-Say","year":"2016","journal-title":"J. Liposome Res."},{"key":"10.1016\/j.lfs.2022.120908_bb0245","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.3109\/03639045.2011.587431","article-title":"Niosomes as a potential drug delivery system for increasing the efficacy and safety of nystatin","volume":"37","author":"El-Ridy","year":"2011","journal-title":"Drug Dev. Ind. Pharm."},{"key":"10.1016\/j.lfs.2022.120908_bb0250","doi-asserted-by":"crossref","first-page":"E106","DOI":"10.1208\/pt0804106","article-title":"Influence of a niosomal formulation on the oral bioavailability of acyclovir in rabbits","volume":"8","author":"Attia","year":"2007","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.lfs.2022.120908_bb0255","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1002\/jps.20709","article-title":"Pharmacokinetics of tamoxifen after intravenous and oral dosing of tamoxifen\u2013hydroxybutenyl-b-cyclodextrin formulations","volume":"96","author":"Buchanan","year":"2007","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.lfs.2022.120908_bb0260","article-title":"Nanomedicine in treatment of breast cancer \u2013 a challenge to conventional therapy","author":"Afzal","year":"2019","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.lfs.2022.120908_bb0265","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/srep41503","article-title":"DOE optimization of nano-based carrier of pregabalin as hydrogel: new therapeutic & chemometric approaches for controlled drug delivery systems","volume":"7","author":"Arafa","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.lfs.2022.120908_bb0270","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.ijbiomac.2020.05.146","article-title":"Metformin-loaded chitosomes for treatment of malignant pleural mesothelioma \u2013 a rare thoracic cancer","volume":"160","author":"Shukla","year":"2020","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.lfs.2022.120908_bb0275","doi-asserted-by":"crossref","first-page":"445","DOI":"10.3390\/pharmaceutics5030445","article-title":"Pectosomes and chitosomes as delivery systems for metronidazole: the one-pot preparation method","volume":"5","author":"Andersen","year":"2013","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.lfs.2022.120908_bb0280","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.ijpharm.2008.05.031","article-title":"Effect of some formulation parameters on flurbiprofen encapsulation and release rates of niosomes prepared from proniosomes","volume":"361","author":"Mokhtar","year":"2008","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.lfs.2022.120908_bb0285","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/j.ijpharm.2015.05.070","article-title":"Preparation and characterization of paclitaxel nanosuspension using novel emulsification method by combining high speed homogenizer and high pressure homogenization","volume":"490","author":"Li","year":"2015","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.lfs.2022.120908_bb0290","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.ijpharm.2016.01.017","article-title":"Transdermal glimepiride delivery system based on optimized ethosomal nano-vesicles: preparation, characterization, in vitro, ex vivo and clinical evaluation","volume":"500","author":"Ahmed","year":"2016","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.lfs.2022.120908_bb0295","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.ijpharm.2007.11.037","article-title":"Innovative bola-surfactant niosomes as topical delivery systems of 5-fluorouracil for the treatment of skin cancer","volume":"353","author":"Paolino","year":"2008","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.lfs.2022.120908_bb0300","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S0378-5173(02)00301-0","article-title":"Studies on a high encapsulation of colchicine by a niosome system","volume":"244","author":"Hao","year":"2002","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.lfs.2022.120908_bb0305","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1208\/s12248-014-9590-y","article-title":"In vitro characterization of a novel polymeric system for preparation of amorphous solid drug dispersions","volume":"16","author":"Mahmoudi","year":"2014","journal-title":"AAPS J."},{"key":"10.1016\/j.lfs.2022.120908_bb0310","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.ijpharm.2015.07.041","article-title":"Cellular uptake, cytotoxicity and in-vivo evaluation of Tamoxifen citrate loaded niosomes","volume":"493","author":"Shaker","year":"2015","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.lfs.2022.120908_bb0315","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.jconrel.2008.09.086","article-title":"Paclitaxel-loaded PEGylated PLGA-based nanoparticles: in vitro and in vivo evaluation","volume":"133","author":"Danhier","year":"2009","journal-title":"J. Control. Release"},{"key":"10.1016\/j.lfs.2022.120908_bb0320","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.ijpharm.2005.11.045","article-title":"Niosomes as carriers for tretinoin: IIIA study into the in vitro cutaneous delivery of vesicle-incorporated tretinoin","volume":"311","author":"Manconi","year":"2006","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.lfs.2022.120908_bb0325","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1080\/02652048.2021.1887383","article-title":"Fluticasone propionate\u2013loaded solid lipid nanoparticles with augmented anti-inflammatory activity: optimisation, characterisation and pharmacodynamic evaluation on rats","volume":"38","author":"Desoqi","year":"2021","journal-title":"J. Microencapsul."},{"key":"10.1016\/j.lfs.2022.120908_bb0330","doi-asserted-by":"crossref","first-page":"513","DOI":"10.3892\/ijmm.2014.1795","article-title":"Valproic acid, an anti-epileptic drug and a histone deacetylase inhibitor, incombination with proteasome inhibitors exerts antiproliferative, pro-apoptotic and chemosensitizing effects in human colorectal cancer cells: underlying molecular mechanisms","volume":"34","author":"Abaza","year":"2014","journal-title":"Int. J. Mol. Med."},{"key":"10.1016\/j.lfs.2022.120908_bb0335","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/0022-1759(83)90303-4","article-title":"Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays","volume":"65","author":"Mosmann","year":"1983","journal-title":"J. Immunol.Methods"},{"key":"10.1016\/j.lfs.2022.120908_bb0340","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1038\/s41418-018-0160-1","article-title":"The AHR represses nucleotide excision repair and apoptosis and contributes to UV-induced skin carcinogenesis","volume":"25","author":"Pollet","year":"2018","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.lfs.2022.120908_bb0345","first-page":"4356","article-title":"Downregulation of FOXK2 is associated with poor prognosis in patients with gastric cancer","volume":"18","author":"Liu","year":"2018","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.lfs.2022.120908_bb0350","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.biochi.2018.11.017","article-title":"Oleate increase neutral lipid accumulation, cellular respiration and rescues palmitate-exposed GLP-1 secreting cells by reducing ceramide-induced ROS","volume":"159","author":"Ntika","year":"2019","journal-title":"Biochimie"},{"key":"10.1016\/j.lfs.2022.120908_bb0355","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1007\/BF01806074","article-title":"Experimentally induced mammary tumors in rats","volume":"39","author":"Russo","year":"1996","journal-title":"Breast Cancer Res. Treat."},{"key":"10.1016\/j.lfs.2022.120908_bb0360","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2021.121057","article-title":"Oleic acid\u2013reinforced PEGylated polymethacrylate transdermal film with enhanced antidyslipidemic activity and bioavailability of atorvastatin: a mechanistic ex-vivo\/in-vivo analysis","volume":"608","author":"El-Say","year":"2021","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.lfs.2022.120908_bb0365","author":"El-Say"},{"key":"10.1016\/j.lfs.2022.120908_bb0370","doi-asserted-by":"crossref","DOI":"10.1007\/s11051-019-4562-x","article-title":"In vitro investigation of anticancer efficacy of carboplatin-loaded PEGylated nanoliposome particles on brain cancer cell lines","volume":"21","author":"Hassanzadeganroudsari","year":"2019","journal-title":"J. Nanoparticle Res."},{"key":"10.1016\/j.lfs.2022.120908_bb0375","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.carbpol.2016.01.010","article-title":"Fine-tuned PEGylation of chitosan to maintain optimal siRNA-nanoplex bioactivity","volume":"143","author":"Gu\u0163oaia","year":"2016","journal-title":"Carbohydr. Polym."},{"key":"10.1016\/j.lfs.2022.120908_bb0380","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.ijpharm.2006.08.002","article-title":"In vitro study of polyoxyethylene alkyl ether niosomes for delivery of insulin","volume":"328","author":"Pardakhty","year":"2007","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.lfs.2022.120908_bb0385","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.3390\/pharmaceutics13111741","article-title":"Cholesterol-based nanovesicles enhance the in vitro cytotoxicity,ex vivo intestinal absorption, and in vivo bioavailability of flutamide","volume":"13","author":"Ali","year":"2021","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.lfs.2022.120908_bb0390","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1208\/s12249-010-9512-y","article-title":"Polyethylene glycol on stability of chitosan microparticulate carrier for protein","volume":"11","author":"Luangtana-Anan","year":"2010","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.lfs.2022.120908_bb0395","article-title":"Enhanced efficacy, cellular uptake, and antiangiogenic activity of the optimized imatinib mesylate-loaded proniosomal-derived nanovesicles","volume":"61","author":"Gardouh","year":"2021","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"10.1016\/j.lfs.2022.120908_bb0400","doi-asserted-by":"crossref","first-page":"15507","DOI":"10.1038\/ncomms15507","article-title":"Conditional internalization of PEGylated nanomedicines by PEG engagers for triple negative breast cancer therapy","volume":"8","author":"Su","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.lfs.2022.120908_bb0405","doi-asserted-by":"crossref","first-page":"8467","DOI":"10.1016\/j.biomaterials.2014.06.032","article-title":"Endocytosis of PEGylated nanoparticles accompanied by structural and free energy changes of the grafted polyethylene glycol","volume":"35","author":"Li","year":"2014","journal-title":"Biomaterials"},{"key":"10.1016\/j.lfs.2022.120908_bb0410","doi-asserted-by":"crossref","first-page":"3404","DOI":"10.1039\/C9BM00323A","article-title":"Enhanced drug internalization and therapeutic efficacy of PEGylated nanoparticles by one-step formulation with anti-mPEG bispecific antibody in intrinsic drug-resistant breast cancer","volume":"7","author":"Cheng","year":"2019","journal-title":"Biomater Sci."},{"key":"10.1016\/j.lfs.2022.120908_bb0415","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1111\/jcmm.13110","article-title":"Overviews on the cellular uptake mechanism of polysaccharide colloidal nanoparticles","volume":"21","author":"Salatin","year":"2017","journal-title":"J. Cell. Mol. Med."},{"key":"10.1016\/j.lfs.2022.120908_bb0420","doi-asserted-by":"crossref","first-page":"6383","DOI":"10.2147\/IJN.S142060","article-title":"Intracellular disposition of chitosan nanoparticles in macrophages: intracellular uptake, exocytosis, and intercellular transport","volume":"12","author":"Jiang","year":"2017","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.lfs.2022.120908_bb0425","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/molecules25204758","article-title":"Understanding the factors influencing chitosan-based nanoparticles-protein corona interaction and drug delivery applications","volume":"25","author":"Moraru","year":"2020","journal-title":"Molecules"},{"key":"10.1016\/j.lfs.2022.120908_bb0430","doi-asserted-by":"crossref","first-page":"963","DOI":"10.3390\/nano10050963","article-title":"Advances in the design of ph-sensitive cubosome liquid crystalline nanocarriers for drug delivery applications","volume":"10","author":"Mertins","year":"2020","journal-title":"Nanomaterials"},{"key":"10.1016\/j.lfs.2022.120908_bb0435","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2022.e08934","article-title":"Liposome-polymer complex for drug delivery system and vaccine stabilization","volume":"8","author":"Sriwidodo","year":"2022","journal-title":"Heliyon"},{"key":"10.1016\/j.lfs.2022.120908_bb0440","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1021\/np300457g","article-title":"Physangulidine A, a withanolide from Physalis angulata, perturbs the cell cycle and induces cell death by apoptosis in prostate cancer cells","volume":"76","author":"Reyes-Reyes","year":"2013","journal-title":"J. Nat. Prod."},{"key":"10.1016\/j.lfs.2022.120908_bb0445","doi-asserted-by":"crossref","first-page":"2232","DOI":"10.3390\/ijms19082232","article-title":"Synthesis, biological evaluation and molecular docking of novel indole-aminoquinazoline hybrids for anticancer properties","volume":"19","author":"Mphahlele","year":"2018","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.lfs.2022.120908_bb0450","doi-asserted-by":"crossref","first-page":"407","DOI":"10.3390\/pharmaceutics14020407","article-title":"PEGylated chitosan nanoparticles encapsulating ascorbic acid and oxaliplatin exhibit dramatic apoptotic effects against breast cancer cells","volume":"14","author":"Fahmy","year":"2022","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.lfs.2022.120908_bb0455","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.bbrc.2018.11.120","article-title":"Identification of a novel SIRT7 inhibitor as anticancer drug candidate","volume":"508","author":"Kim","year":"2019","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.lfs.2022.120908_bb0460","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1002\/ijc.10881","article-title":"Direct interaction with and activation of p53 by SMAR1 retards cell-cycle progression at G2\/M phase and delays tumor growth in mice","volume":"103","author":"Kaul","year":"2003","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.lfs.2022.120908_bb0465","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1016\/j.ejmech.2014.08.040","article-title":"Synthesis and biological evaluation of hydroxycinnamic acid hydrazide derivatives as inducer of caspase-3","volume":"85","author":"Wu","year":"2014","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.lfs.2022.120908_bb0470","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1007\/s12010-018-2907-z","article-title":"Enhanced induction of apoptosis in HaCaT cells by luteolin encapsulated in PEGylated liposomes\u2014role of Caspase-3\/Caspase-14","volume":"188","author":"Sinha","year":"2019","journal-title":"Appl. Biochem. Biotechnol."},{"key":"10.1016\/j.lfs.2022.120908_bb0475","doi-asserted-by":"crossref","first-page":"2181","DOI":"10.3390\/pharmaceutics13122181","article-title":"Pegylated liposomes remotely loaded with the combination of doxorubicin, quinine, and indocyanine green enable successful treatment of multidrug-resistant tumors","volume":"13","author":"Portnoy","year":"2021","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.lfs.2022.120908_bb0480","doi-asserted-by":"crossref","first-page":"2210","DOI":"10.3390\/ijms22042210","article-title":"Therapeutic targeting of MicroRNAs in the tumor microenvironment","volume":"22","author":"Raue","year":"2021","journal-title":"Int. J. Mol. Sci."}],"container-title":["Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320522006087?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320522006087?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,8,6]],"date-time":"2025-08-06T07:33:30Z","timestamp":1754465610000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0024320522006087"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10]]},"references-count":96,"alternative-id":["S0024320522006087"],"URL":"https:\/\/doi.org\/10.1016\/j.lfs.2022.120908","relation":{},"ISSN":["0024-3205"],"issn-type":[{"value":"0024-3205","type":"print"}],"subject":[],"published":{"date-parts":[[2022,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effect of nanovesicular surface-functionalization via chitosan and\/or PEGylation on cytotoxicity of tamoxifen in induced-breast cancer model","name":"articletitle","label":"Article Title"},{"value":"Life Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lfs.2022.120908","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"120908"}}